We are live on ! Find out more
EWA

EverSource Wealth Advisors Portfolio holdings

AUM $2.97B
1-Year Est. Return 28.74%
This Fund
S&P 500
This Quarter Est. Return
+2.58%
1 Year Est. Return
+28.74%
3 Year Est. Return
+89.7%
5 Year Est. Return
10 Year Est. Return
AUM
$2.72B
AUM Growth
+$190M
Cap. Flow
+$157M
Cap. Flow %
5.78%
Top 10 Hldgs %
20.63%
Holding
4,507
New
186
Increased
1,795
Reduced
1,792
Closed
236

Sector Composition

Rank Sector Weight
1 Technology 12.21%
2 Financials 7.71%
3 Consumer Discretionary 5.3%
4 Industrials 3.51%
5 Communication Services 3.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMSC icon
3251
American Superconductor
AMSC
$1.39B
$3.57K ﹤0.01%
124
-73
-37% -$3.16K
WEAV icon
3252
Weave Communications
WEAV
$548M
$3.57K ﹤0.01%
470
+442
+1,579% +$2.94K
USBC
3253
USBC Inc
USBC
$124M
$3.54K ﹤0.01%
5,583
VTS icon
3254
Vitesse Energy
VTS
$626M
$3.54K ﹤0.01%
184
-191
-51% -$4.08K
CXW icon
3255
CoreCivic
CXW
$3.03B
$3.54K ﹤0.01%
185
-85
-31% -$1.56K
LION icon
3256
Lionsgate Studios
LION
$3.85B
$3.53K ﹤0.01%
387
-2,577
-87% -$18.3K
CHRS icon
3257
Coherus Oncology
CHRS
$222M
$3.52K ﹤0.01%
2,479
+544
+28% +$793
UNTY icon
3258
Unity Bancorp
UNTY
$593M
$3.52K ﹤0.01%
68
+59
+656% +$2.94K
FFWM
3259
DELISTED
First Foundation Inc
FFWM
$3.51K ﹤0.01%
570
+115
+25% +$644
CIM
3260
Chimera Investment
CIM
$1.06B
$3.49K ﹤0.01%
281
-345
-55% -$4.38K
ABR icon
3261
Arbor Realty Trust
ABR
$979M
$3.49K ﹤0.01%
450
-230
-34% -$2.25K
RAPP
3262
Rapport Therapeutics
RAPP
$2.01B
$3.49K ﹤0.01%
115
EWU icon
3263
iShares MSCI United Kingdom ETF
EWU
$4.09B
$3.47K ﹤0.01%
79
DENN
3264
DELISTED
Denny's
DENN
$3.47K ﹤0.01%
558
-126
-18% -$714
UTMD icon
3265
Utah Medical Products
UTMD
$226M
$3.47K ﹤0.01%
62
-37
-37% -$2.15K
DAWN
3266
DELISTED
Day One Biopharmaceuticals
DAWN
$3.47K ﹤0.01%
372
+141
+61% +$1.18K
BB icon
3267
BlackBerry
BB
$4.74B
$3.46K ﹤0.01%
914
+407
+80% +$1.79K
HOG icon
3268
Harley-Davidson
HOG
$2.66B
$3.46K ﹤0.01%
169
-775
-82% -$19.1K
ARRY icon
3269
Array Technologies
ARRY
$785M
$3.44K ﹤0.01%
373
TBLA icon
3270
Taboola.com
TBLA
$1.37B
$3.44K ﹤0.01%
746
+18
+2% +$68
BFOR icon
3271
Barron's 400 ETF
BFOR
$231M
$3.42K ﹤0.01%
168
+4
+2% +$81
DNLI icon
3272
Denali Therapeutics
DNLI
$3.82B
$3.42K ﹤0.01%
207
+41
+25% +$692
LIND icon
3273
Lindblad Expeditions
LIND
$1.95B
$3.42K ﹤0.01%
237
-13
-5% -$164
GHM icon
3274
Graham Corp
GHM
$1.17B
$3.4K ﹤0.01%
53
-2
-4% -$121
DFTX
3275
Definium Therapeutics
DFTX
$5.57B
$3.4K ﹤0.01%
254
+150
+144% +$1.86K

Similar funds

EverSource Wealth Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, EverSource Wealth Advisors held 4,507 positions worth $2.72B, up 7.5% from $2.53B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

EverSource Wealth Advisors deployed $157M of net new capital in Q4 2025, opening 186 new positions and adding to 1,795 existing holdings. Its largest new stake was T. Rowe Price Blue Chip Growth ETF: 48,629 shares worth $2.42M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Sovereign's Capital Flourish Fund, an estimated $8.36M trimmed.

  • EverSource Wealth Advisors's largest Q4 2025 buy was T. Rowe Price Blue Chip Growth ETF: 48,629 shares worth $2.42M.
  • EverSource Wealth Advisors added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q4 2025, an estimated $17.8M increase.
  • EverSource Wealth Advisors's biggest Q4 2025 reduction was Sovereign's Capital Flourish Fund, cutting an estimated $8.36M.
  • EverSource Wealth Advisors fully exited Direxion Daily Technology Bear 3x ETF in Q4 2025, selling an estimated $882K.
  • EverSource Wealth Advisors's ten largest holdings make up 21% of its $2.72B portfolio in Q4 2025.
  • EverSource Wealth Advisors opened 186 new positions and closed 236 in Q4 2025.
  • EverSource Wealth Advisors's portfolio value rose 7.5% quarter-over-quarter to $2.72B.

Based on EverSource Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.